Inogen reported $-9.42M in EBITDA for its fiscal quarter ending in September of 2023.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 26.8M 480K Sep/2026
Baxter International USD 474M 165M Jun/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Cooper Companies USD 67.9M 255.5M Mar/2026
Dexcom USD 435.2M 46.5M Sep/2026
Edwards Lifesciences USD 562.2M 6.6M Jun/2026
Globus Medical USD 262.21M 17.63M Sep/2026
Insulet USD 233.7M 33.9M Sep/2026
Medtronic USD 2.63B 174M Jun/2026
Orthofix International USD 27.88M 2.77M Dec/2025
Philips EUR 772M 138M Sep/2026
ResMed USD 533.74M 26.04M Sep/2026
Steris USD 413.1M 29.9M Jun/2026
Stryker USD 1.83B 102M Sep/2026
Tandem Diabetes Care USD 18.04M 11.62M Sep/2026
Teleflex USD 122.91M 47.28M Jun/2026
X T L Biopharmaceuticals USD -479K 19K Dec/2024
Zimmer Biomet Holdings USD 634.8M 195.7M Sep/2026